Coordinate Regulation of Mature Dopaminergic Axon Morphology by Macroautophagy and the PTEN Signaling Pathway

English version České info

Macroautophagy is a conserved mechanism for the bulk degradation of proteins and organelles. Pathological studies have implicated defective macroautophagy in neurodegeneration, but physiological functions of macroautophagy in adult neurons remain unclear. Here we show that Atg7, an essential macroautophagy component, regulates dopaminergic axon terminal morphology. Mature Atg7-deficient midbrain dopamine (DA) neurons harbored selectively enlarged axonal terminals. This contrasted with the phenotype of DA neurons deficient in Pten – a key negative regulator of the mTOR kinase signaling pathway and neuron size – that displayed enlarged soma but unaltered axon terminals. Surprisingly, concomitant deficiency of both Atg7 and Pten led to a dramatic enhancement of axon terminal enlargement relative to Atg7 deletion alone. Similar genetic interactions between Atg7 and Pten were observed in the context of DA turnover and DA-dependent locomotor behaviors. These data suggest a model for morphological regulation of mature dopaminergic axon terminals whereby the impact of mTOR pathway is suppressed by macroautophagy.

Vyšlo v časopise: Coordinate Regulation of Mature Dopaminergic Axon Morphology by Macroautophagy and the PTEN Signaling Pathway. PLoS Genet 9(10): e32767. doi:10.1371/journal.pgen.1003845
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003845

Souhrn

Zdroje

1. LevineB, KlionskyDJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463–477.

2. KlionskyDJ (2006) Neurodegeneration: good riddance to bad rubbish. Nature 441: 819–820.

3. HaraT, NakamuraK, MatsuiM, YamamotoA, NakaharaY, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885–889.

4. KomatsuM, WaguriS, ChibaT, MurataS, IwataJ, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880–884.

5. KomatsuM, WangQJ, HolsteinGR, FriedrichVLJr, IwataJ, et al. (2007) Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci U S A 104: 14489–14494.

6. NishiyamaJ, MiuraE, MizushimaN, WatanabeM, YuzakiM (2007) Aberrant membranes and double-membrane structures accumulate in the axons of Atg5-null Purkinje cells before neuronal death. Autophagy 3: 591–596.

7. WanHI, DiAntonioA, FetterRD, BergstromK, StraussR, et al. (2000) Highwire regulates synaptic growth in Drosophila. Neuron 26: 313–329.

8. BackmanSA, StambolicV, SuzukiA, HaightJ, EliaA, et al. (2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29: 396–403.

9. KwonCH, ZhuX, ZhangJ, KnoopLL, TharpR, et al. (2001) Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29: 404–411.

10. KwonCH, LuikartBW, PowellCM, ZhouJ, MathenySA, et al. (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377–388.

11. ChalhoubN, ZhuG, ZhuX, BakerSJ (2009) Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains. Genes Dev 23: 1619–1624.

12. LuikartBW, SchnellE, WashburnEK, BensenAL, TovarKR, et al. (2011) Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci 31: 4345–4354.

13. SperowM, BerryRB, BayazitovIT, ZhuG, BakerSJ, et al. (2012) Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration. J Physiol 590: 777–792.

14. Diaz-RuizO, ZapataA, ShanL, ZhangY, TomacAC, et al. (2009) Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PLoS One 4: e7027.

15. DomanskyiA, GeisslerC, VinnikovIA, AlterH, SchoberA, et al. (2011) Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models. FASEB J 25: 2898–2910.

16. InoueK, RispoliJ, KaphzanH, KlannE, ChenEI, et al. (2012) Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway. Mol Neurodegener 7: 48.

17. ZhuangX, MassonJ, GingrichJA, RayportS, HenR (2005) Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods 143: 27–32.

18. KomatsuM, WaguriS, UenoT, IwataJ, MurataS, et al. (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169: 425–434.

19. FriedmanLG, LachenmayerML, WangJ, HeL, PouloseSM, et al. (2012) Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of alpha-synuclein and LRRK2 in the brain. J Neurosci 32: 7585–7593.

20. AhmedI, LiangY, SchoolsS, DawsonVL, DawsonTM, et al. (2012) Development and characterization of a new Parkinson's disease model resulting from impaired autophagy. J Neurosci 32: 16503–16509.

21. LeeCH, InokiK, GuanKL (2007) mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 47: 443–467.

22. BackmanS, StambolicV, MakT (2002) PTEN function in mammalian cell size regulation. Curr Opin Neurobiol 12: 516–522.

23. KwonCH, ZhuX, ZhangJ, BakerSJ (2003) mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U S A 100: 12923–12928.

24. MizushimaN, KomatsuM (2011) Autophagy: renovation of cells and tissues. Cell 147: 728–741.

25. HayN, SonenbergN (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926–1945.

26. HernandezD, TorresCA, SetlikW, CebrianC, MosharovEV, et al. (2012) Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74: 277–284.

27. MontagneJ, StewartMJ, StockerH, HafenE, KozmaSC, et al. (1999) Drosophila S6 kinase: a regulator of cell size. Science 285: 2126–2129.

28. NguyenKT, TajmirP, LinCH, LiadisN, ZhuXD, et al. (2006) Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol Cell Biol 26: 4511–4518.

29. StilesBL, Kuralwalla-MartinezC, GuoW, GregorianC, WangY, et al. (2006) Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Mol Cell Biol 26: 2772–2781.

30. ChalhoubN, KozmaSC, BakerSJ (2006) S6k1 is not required for Pten-deficient neuronal hypertrophy. Brain Res 1100: 32–41.

31. ShenW, GanetzkyB (2009) Autophagy promotes synapse development in Drosophila. J Cell Biol 187: 71–79.

32. HedgecockEM, CulottiJG, ThomsonJN, PerkinsLA (1985) Axonal guidance mutants of Caenorhabditis elegans identified by filling sensory neurons with fluorescein dyes. Dev Biol 111: 158–170.

33. ScottRC, JuhaszG, NeufeldTP (2007) Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Curr Biol 17: 1–11.

34. TomodaT, KimJH, ZhanC, HattenME (2004) Role of Unc51.1 and its binding partners in CNS axon outgrowth. Genes Dev 18: 541–558.

35. TodaH, MochizukiH, FloresR (2008) UNC-51/ATG1 kinase regulates axonal transport by mediating motor-cargo assembly. Genes Dev 22: 3292–3307.

36. LohSH, FrancescutL, LingorP, BahrM, NicoteraP (2008) Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen. Cell Death Differ 15: 283–298.

37. ArevaloJC, WuSH (2006) Neurotrophin signaling: many exciting surprises!. Cell Mol Life Sci 63: 1523–1537.

38. ReichardtLF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545–1564.

39. TomacA, LindqvistE, LinLF, OgrenSO, YoungD, et al. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335–339.

40. HudsonJ, GranholmAC, GerhardtGA, HenryMA, HoffmanA, et al. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull 36: 425–432.

41. RosenbladC, KirikD, BjorklundA (2000) Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp Neurol 161: 503–516.

42. RangasamySB, SoderstromK, BakayRA, KordowerJH (2010) Neurotrophic factor therapy for Parkinson's disease. Prog Brain Res 184: 237–264.

43. ZhangM, SchekmanR (2013) Cell biology. Unconventional secretion, unconventional solutions. Science 340: 559–561.

44. BourgeronT (2009) A synaptic trek to autism. Curr Opin Neurobiol 19: 231–234.

45. DelormeR, EyE, ToroR, LeboyerM, GillbergC, et al. (2013) Progress toward treatments for synaptic defects in autism. Nat Med 19: 685–694.

46. NakamuraK, SekineY, OuchiY, TsujiiM, YoshikawaE, et al. (2010) Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 67: 59–68.

47. GadowKD, DevincentCJ, OlvetDM, PisarevskayaV, HatchwellE (2010) Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder and repetitive behaviors in children with autism spectrum disorder. Eur J Neurosci 32: 1058–1065.

48. TaurinesR, SchwenckC, WesterwaldE, SachseM, SiniatchkinM, et al. (2012) ADHD and autism: differential diagnosis or overlapping traits? A selective review. Atten Defic Hyperact Disord 4: 115–139.

49. RommelseNN, FrankeB, GeurtsHM, HartmanCA, BuitelaarJK (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 19: 281–295.

50. GlessnerJT, WangK, CaiG, KorvatskaO, KimCE, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569–573.

51. BucanM, AbrahamsBS, WangK, GlessnerJT, HermanEI, et al. (2009) Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 5: e1000536.

52. ScheuerleA, WilsonK (2011) PARK2 copy number aberrations in two children presenting with autism spectrum disorder: further support of an association and possible evidence for a new microdeletion/microduplication syndrome. Am J Med Genet B Neuropsychiatr Genet 156B: 413–420.

53. GroszerM, EricksonR, Scripture-AdamsDD, LescheR, TrumppA, et al. (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294: 2186–2189.

54. SpielewoyC, BialaG, RoubertC, HamonM, BetancurC, et al. (2001) Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. Psychopharmacology (Berl) 159: 2–9.

55. MengualE, PickelVM (2004) Regional and subcellular compartmentation of the dopamine transporter and tyrosine hydroxylase in the rat ventral pallidum. J Comp Neurol 468: 395–409.

56. MacLeodD, DowmanJ, HammondR, LeeteT, InoueK, et al. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52: 587–593.

57. TengL, CrooksPA, SonsallaPK, DwoskinLP (1997) Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake. J Pharmacol Exp Ther 280: 1432–1444.

58. YangL, CalingasanNY, ChenJ, LeyJJ, BeckerDA, et al. (2005) A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities. Exp Neurol 191: 86–93.

59. IwasatoT, NomuraR, AndoR, IkedaT, TanakaM, et al. (2004) Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice. Genesis 38: 130–138.